What to watch with CYP2D6 and weight loss?

CYP2D6 is a key enzyme in the cytochrome P450 system, responsible for metabolizing about 20–25% of commonly prescribed drugs. There is no strong direct evidence that any specific CYP2D6 variant determines weight loss success through diet or exercise. However, the genotype can be indirectly relevant: many medications that affect body weight (e.g., certain antidepressants, beta-blockers, opioids, antipsychotics) are metabolized by CYP2D6. In poor metabolizers, these drugs can reach higher blood levels, potentially causing increased side effects like fatigue, nausea, or appetite changes that may hinder weight loss. Conversely, ultrarapid metabolizers may experience reduced drug efficacy. Some over-the-counter 'fat burners' or herbal supplements (e.g., St. John's wort) also interact with CYP2D6. Importantly, most direct-to-consumer genetic tests provide only a rough classification (e.g., 'normal' vs. 'slow') and do not account for polypharmacy or other genetic factors. The evidence for personalizing weight loss solely based on CYP2D6 is weak to moderate. Lifestyle, calorie balance, and exercise remain dominant. Consult a physician or pharmacist before changing medications or taking supplements based on your genotype.